These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30691675)

  • 1. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
    Franceschini G; Di Leone A; Masetti R
    Am J Surg; 2019 Nov; 218(5):1031-1032. PubMed ID: 30691675
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of anticipated financial burden on patient decision to undergo contralateral prophylactic mastectomy.
    Huang J; Chagpar A
    Surgery; 2018 Oct; 164(4):856-865. PubMed ID: 30093279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
    Franceschini G; Di Leone A; Masetti R
    Patient Educ Couns; 2019 Aug; 102(8):1573-1574. PubMed ID: 30905494
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion: Complications of Contralateral Prophylactic Mastectomy: Do They Delay Adjuvant Therapy?
    Chen AD; Lin SJ
    Plast Reconstr Surg; 2020 Nov; 146(5):954-955. PubMed ID: 33136937
    [No Abstract]   [Full Text] [Related]  

  • 5. Contralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider Recommendations.
    Fayanju OM; Hwang ES
    JAMA Surg; 2017 Mar; 152(3):282-283. PubMed ID: 28002558
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
    Tuttle TM; Burke EE; Hui JYC
    Ann Surg Oncol; 2021 Sep; 28(9):4764-4766. PubMed ID: 33796999
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg; 2022 Mar; 223(3):538. PubMed ID: 35177234
    [No Abstract]   [Full Text] [Related]  

  • 9. Discussion: The Cost of Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer.
    Matros E; Disa JJ
    Plast Reconstr Surg; 2018 May; 141(5):1103-1104. PubMed ID: 29389716
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of breast reconstruction following prophylactic bilateral mastectomy.
    Lim DW; Narod SA
    Breast J; 2020 Sep; 26(9):1637-1638. PubMed ID: 32783312
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilateral Prophylactic Mastectomy and Immediate Breast Reconstruction in High-Risk Women: The Importance of Health-Related Quality of Life in Decision Making.
    Lemaine V
    Ann Surg Oncol; 2017 Sep; 24(9):2434-2435. PubMed ID: 28600730
    [No Abstract]   [Full Text] [Related]  

  • 12. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Contralateral Prophylactic Mastectomy-Moving Beyond Sociodemographic Factors.
    Oseni TO; Zhang B
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):834-835. PubMed ID: 31673940
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making.
    Franceschini G; Masetti R
    Breast J; 2019 May; 25(3):564-565. PubMed ID: 30964221
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies.
    Eisemann BS; Spiegel AJ
    Clin Plast Surg; 2018 Jan; 45(1):129-136. PubMed ID: 29080654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
    Greener JR; Bass SB; Lepore SJ
    J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science.
    Sacks GD; Morrow M
    J Clin Oncol; 2021 Feb; 39(4):269-272. PubMed ID: 33275488
    [No Abstract]   [Full Text] [Related]  

  • 18. Discussion: Complications Associated with Contralateral Prophylactic Mastectomy: A Systematic Review and Meta-Analysis.
    Luce EA
    Plast Reconstr Surg; 2022 Oct; 150():73S-74S. PubMed ID: 36170450
    [No Abstract]   [Full Text] [Related]  

  • 19. The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis.
    Bucknor A; Chattha A; Ultee K; Wu W; Kamali P; Bletsis P; Chen A; Lee BT; Cronin C; Lin SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):301-310. PubMed ID: 28634720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement.
    Tuttle TM; Barrio AV; Klimberg VS; Giuliano AE; Chavez-MacGregor M; Buum HA; McMasters KM
    Ann Surg Oncol; 2017 Jan; 24(1):1-2. PubMed ID: 27783164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.